ImmunoGen, Inc. provided earnings guidance for the year 2022. For the year, the company now expects revenues between $80 million and $90 million.
1st Jan change | Capi. | |
---|---|---|
+66.91% | 62.86B | |
-1.30% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.45% | 26.46B | |
-21.93% | 18.9B | |
+4.01% | 12.67B | |
+24.01% | 12.27B | |
+28.88% | 12.07B |